CLINICAL TRIAL: SAPROPTERIN EXPANDED ACCESS PROGRAM (SEAP)

临床试验：SAPPROTERIN 扩展获取计划 (SEAP)

• 批准号: 7724974
• 负责人: WILLIAM L. NYHAN
• 金额: $ 0.18万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-12-01 至 2008-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7724974
• 关键词: Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Hyperphenylalaninaemias; Institution; Patients; Pharmaceutical Preparations; Research; Research Personnel; Resources; Safety; Source; United States National Institutes of Health; programs

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To provide patients with hyperphenylalaninemia (HPA) due to Phenylketonuria (PKU) access to sapropterin dihydrochloride and to collect more information about the safety of the drug in an expanded access program (EAP) until commercial product is available.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 为患者提供苯基酮（PKU）访问二氢氯化物的苯基酮（PKU）引起的患者，并收集有关该药物安全性的更多信息，直到商业产品可用。